Spherebio
1 known investors
Find your way into Spherebio
547 people in our graph share verified history with the Spherebio team — schools, employers, funds. One of them is your warm intro.
Arturo Litvinunlockedknows Guido Molina · together at University of Buenos Aires (overlapped)
×2knows the team · via University of Buenos Aires
×3knows the team · via Massachusetts Institute of Technology
×2knows the team · via Harvard Medical School
×2knows the team · via IQVIA
knows the team · via MIT Professional Education
SphereBio develops individualized cancer immunotherapies using engineered biological vesicles (OncoSpheres™) that capture a patient's own tumor antigens and deliver them into immune cells to train the immune system against cancer. The company combines biotechnology, synthetic virology, and AI to create individualized cancer vaccines manufactured without sequencing in under seven days.
Founders & leadership
JP
Julieta PortainCOO & Co-founderJulieta Porta is COO and co-founder of SphereBio Technologies, where she leads operations, strategy, and finance alongside co-founders Guido Molina (Ph.D. in virology and immunology) and Martín Guerrero (M.D. and Ph.D. in machine learning applied to cancer genomics).
GM
Guido MolinainCo-founder (Molecular Biologist)Guido Molina holds a PhD in Molecular Biology from the University of Buenos Aires and has over a decade of research experience in immunology and virology at institutions including CONICET, INTA, and ICGEB. He is Chief Scientific Officer at SphereBio, where he leads technology development for individualized cancer immunotherapies.
MG
Martin GuerreroinCo-founder (Physician & Bioinformatician)Martin Guerrero is a physician and bioinformatician who serves as co-founder and CEO of SphereBio, which develops individualized cancer vaccines using engineered biological vesicles to train immune systems against cancer. He brings over a decade of experience in healthcare and translational science, with expertise in oncology, immunotherapy, and intracellular delivery mechanisms.
Investors · 1
Frequently asked questions
- What does Spherebio do?
- SphereBio develops individualized cancer immunotherapies using engineered biological vesicles (OncoSpheres™) that capture a patient's own tumor antigens and deliver them into immune cells to train the immune system against cancer. The company combines biotechnology, synthetic virology, and AI to create individualized cancer vaccines manufactured without sequencing in under seven days.
- Who founded Spherebio?
- Spherebio was founded by Julieta Porta, Guido Molina, Martin Guerrero.
- Who are Spherebio's investors?
- Spherebio's investors include GRIDX.